These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 11391801

  • 1. Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis.
    Inoue H, Furukawa T, Sunamura M, Takeda K, Matsuno S, Horii A.
    Genes Chromosomes Cancer; 2001 Jul; 31(3):295-9. PubMed ID: 11391801
    [Abstract] [Full Text] [Related]

  • 2. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.
    Sasaki S, Yamamoto H, Kaneto H, Ozeki I, Adachi Y, Takagi H, Matsumoto T, Itoh H, Nagakawa T, Miyakawa H, Muraoka S, Fujinaga A, Suga T, Satoh M, Itoh F, Endo T, Imai K.
    Oncol Rep; 2003 Jul; 10(1):21-5. PubMed ID: 12469138
    [Abstract] [Full Text] [Related]

  • 3. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
    Moore PS, Orlandini S, Zamboni G, Capelli P, Rigaud G, Falconi M, Bassi C, Lemoine NR, Scarpa A.
    Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
    [Abstract] [Full Text] [Related]

  • 4. Suppression of the tumorigenic phenotype by chromosome 18 transfer into pancreatic cancer cell lines.
    Lefter LP, Furukawa T, Sunamura M, Duda DG, Takeda K, Kotobuki N, Oshimura M, Matsuno S, Horii A.
    Genes Chromosomes Cancer; 2002 Jun; 34(2):234-42. PubMed ID: 11979557
    [Abstract] [Full Text] [Related]

  • 5. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
    Tarafa G, Villanueva A, Farré L, Rodríguez J, Musulén E, Reyes G, Seminago R, Olmedo E, Paules AB, Peinado MA, Bachs O, Capellá G.
    Oncogene; 2000 Jan 27; 19(4):546-55. PubMed ID: 10698524
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
    Biankin AV, Kench JG, Morey AL, Lee CS, Biankin SA, Head DR, Hugh TB, Henshall SM, Sutherland RL.
    Cancer Res; 2001 Dec 15; 61(24):8830-7. PubMed ID: 11751405
    [Abstract] [Full Text] [Related]

  • 7. Inactivation of Smad4 in gastric carcinomas.
    Powell SM, Harper JC, Hamilton SR, Robinson CR, Cummings OW.
    Cancer Res; 1997 Oct 01; 57(19):4221-4. PubMed ID: 9331080
    [Abstract] [Full Text] [Related]

  • 8. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
    Hilgers W, Song JJ, Haye M, Hruban RR, Kern SE, Fearon ER.
    Genes Chromosomes Cancer; 2000 Apr 01; 27(4):353-7. PubMed ID: 10719364
    [Abstract] [Full Text] [Related]

  • 9. SMAD4/DPC4 and pancreatic cancer survival. Commentary re: M. Tascilar et al., The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin. Cancer Res., 7: 4115-4121, 2001.
    Liu F.
    Clin Cancer Res; 2001 Dec 01; 7(12):3853-6. PubMed ID: 11751474
    [No Abstract] [Full Text] [Related]

  • 10. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma.
    Yatsuoka T, Sunamura M, Furukawa T, Fukushige S, Yokoyama T, Inoue H, Shibuya K, Takeda K, Matsuno S, Horii A.
    Am J Gastroenterol; 2000 Aug 01; 95(8):2080-5. PubMed ID: 10950061
    [Abstract] [Full Text] [Related]

  • 11. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis.
    Lüttges J, Galehdari H, Bröcker V, Schwarte-Waldhoff I, Henne-Bruns D, Klöppel G, Schmiegel W, Hahn SA.
    Am J Pathol; 2001 May 01; 158(5):1677-83. PubMed ID: 11337365
    [Abstract] [Full Text] [Related]

  • 12. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
    Popović Hadzija M, Radosevic S, Kovacević D, Lukac J, Hadzija M, Spaventi R, Pavelić K, Kapitanović S.
    Mutat Res; 2004 Apr 14; 548(1-2):61-73. PubMed ID: 15063137
    [Abstract] [Full Text] [Related]

  • 13. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
    Wada K.
    J Hepatobiliary Pancreat Surg; 2002 Apr 14; 9(1):76-85. PubMed ID: 12021900
    [Abstract] [Full Text] [Related]

  • 14. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
    Kojima K, Vickers SM, Adsay NV, Jhala NC, Kim HG, Schoeb TR, Grizzle WE, Klug CA.
    Cancer Res; 2007 Sep 01; 67(17):8121-30. PubMed ID: 17804724
    [Abstract] [Full Text] [Related]

  • 15. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas].
    Gu LJ, Chen J, Liu TH, Cui QC, Lu ZH, Li L, Gao J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr 01; 24(2):165-9. PubMed ID: 12905795
    [Abstract] [Full Text] [Related]

  • 16. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors.
    Hessman O, Lindberg D, Einarsson A, Lillhager P, Carling T, Grimelius L, Eriksson B, Akerström G, Westin G, Skogseid B.
    Genes Chromosomes Cancer; 1999 Nov 01; 26(3):258-64. PubMed ID: 10502325
    [Abstract] [Full Text] [Related]

  • 17. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV, Basturk O, Cheng JD, Andea AA.
    Semin Radiat Oncol; 2005 Oct 01; 15(4):254-64. PubMed ID: 16183479
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.